|
|
|
|
|
|
|
|
|
|
Previous: CVF TECHNOLOGIES CORP, 10QSB, EX-11, 2000-08-14 |
Next: PRAECIS PHARMACEUTICALS INC, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 1,298,930
<SECURITIES> 0
<RECEIVABLES> 3,098,637
<ALLOWANCES> 0
<INVENTORY> 1,143,160
<CURRENT-ASSETS> 7,017,405
<PP&E> 500,915
<DEPRECIATION> 0
<TOTAL-ASSETS> 24,720,797
<CURRENT-LIABILITIES> 5,728,966
<BONDS> 336,695
456,250
350
<COMMON> 8,087
<OTHER-SE> 11,410,043
<TOTAL-LIABILITY-AND-EQUITY> 24,720,797
<SALES> 8,336,117
<TOTAL-REVENUES> 8,336,117
<CGS> 7,102,795
<TOTAL-COSTS> 7,102,795
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (3,237,217)
<INCOME-TAX> 1,427
<INCOME-CONTINUING> (3,238,644)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,238,644)
<EPS-BASIC> (.47)
<EPS-DILUTED> (.47)
</TABLE>
|
|